推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

BMC CANCER

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 BMC CANCER最新评论:2024.01.19投稿,20240402接收,20240408online 1次大修,修改后直接录用 (2024-04-09)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


BMC CANCER期刊基本信息Hello,您是该期刊的第223837位访客

基本信息 登录收藏
期刊名字BMC CANCERBMC CANCER

BMC CANCER
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.4
58人评分
我要评分

声誉
7.1

影响力
5.5

速度
7.9

期刊ISSN1471-2407
微信扫码收藏此期刊
2022-2023最新影响因子
(数据来源于搜索引擎)
3.8 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:3.334
2022-2023自引率2.60%点击查看自引率趋势图
五年影响因子4.3
h-index 111
CiteScore
CiteScoreSJRSNIPCiteScore排名
6.801.1371.166
学科分区排名百分位
大类:Medicine
小类:Oncology
Q2107 / 366
大类:Medicine
小类:Genetics
Q2103 / 328
大类:Medicine
小类:Cancer Research
Q293 / 214

期刊简介
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
期刊官方网站http://bmccancer.biomedcentral.com
期刊投稿网址https://author-welcome.nature.com/12885
作者指南网址http://bmccancer.biomedcentral.com/submission-guidelines
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足BMC CANCER的语言要求,还能让BMC CANCER编辑和审稿人得到更好的审稿体验,让稿件最大限度地被BMC CANCER编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( GBP2390; USD3190; EUR2790; )
文章处理费豁免:查看说明

其他费用:没有
期刊主题关键词:cancer
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardOpen peer review
通讯方式BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL
出版商BioMed Central
涉及的研究方向医学-肿瘤学
出版国家或地区ENGLAND
出版语言English
出版周期Irregular
出版年份2001
年文章数 1339点击查看年文章数趋势图
Gold OA文章占比99.43%
研究类文章占比:
文章 ÷(文章 + 综述)
96.42%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:2区

按学科分区JIF分区JIF排名JIF百分位
学科:ONCOLOGY
类别:SCIE
Q2109/241
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区2区3区
ONCOLOGY
肿瘤学
2区1区3区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区4区
ONCOLOGY
肿瘤学
4区1区3区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区2区4区
ONCOLOGY
肿瘤学
2区3区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1471-2407%5BISSN%5D
平均审稿速度网友分享经验:
平均6.8月
平均录用比例网友分享经验:
约38.12%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在BMC CANCER顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 BMC CANCER期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 BMC CANCER中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
BMC CANCER上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    Nature Reviews Clinical Oncology12775.50
    NATURE REVIEWS CANCER39696.70
    LANCET ONCOLOGY27462.00
    ANNALS OF ONCOLOGY21063.00
    CANCER CELL29552.90
    JOURNAL OF CLINICAL ONCOLOGY49439.60
    SEMINARS IN CANCER BIOLOGY13420.00
    CANCER TREATMENT REVIEWS11620.70
    CLINICAL CANCER RESEARCH29221.80
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE606719
    BIOMATERIALS517499
    BIOMEDICINE & PHARMACOTHERAPY469749
    Journal of Materials Chemistry B462856
    Frontiers in Pharmacology454451
    Frontiers in Immunology426140
    JOURNAL OF ETHNOPHARMACOLOGY409465
    COLLOIDS AND SURFACES B-BIOINTERFACES406481
    Frontiers in Oncology387477
    Acta Biomaterialia379049
  •  

    BMC CANCER BMC CANCER
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Vitamin D receptor prevents tumour development by regulating the Wnt/beta-catenin signalling pathway in human colorectal cancer

    Author: Yu, Jie; Sun, Qi; Hui, Yi; Xu, Jinping; Shi, Pancheng; Chen, Yu; Chen, Yunzhao
    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-023-10690-z
        PubMed      DOI
    2.Effects of preoperative albumin-to-globulin ratio on overall survival and quality of life in esophageal cell squamous carcinoma patients: a prospective cohort study

    Author: Zhang, Juwei; Lin, Zheng; Zhou, Jinsong; Huang, Yue; Chen, Siting; Deng, Yuan; Qiu, Minglian; Chen, Yuanmei; Hu, Zhijian
    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-023-10809-2
        PubMed      DOI
    3.Automated Breast Ultrasound (ABUS)-based radiomics nomogram: an individualized tool for predicting axillary lymph node tumor burden in patients with early breast cancer

    Author: Chen, Yu; Xie, Yongwei; Li, Bo; Shao, Hua; Na, Ziyue; Wang, Qiucheng; Jing, Hui
    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-023-10743-3
        PubMed      DOI
    4.Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer

    Author: Li, Jieqing
    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-023-10774-w
        PubMed      DOI
    5.Prognostic significance of inflammatory and nutritional markers in perioperative period for patients with advanced gastric cancer

    Author: Zhang, Ruolan; Hu, Can; Zhang, Jiaqing; Zhang, Yanqiang; Yuan, Li; Yu, Pengcheng; Wang, Yi; Bao, Zhehan; Cao, Mengxuan; Ruan, Rongwei; Cheng, Xiangdong; Xu, Zhiyuan
    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-022-10479-6
        PubMed      DOI
    6.Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients

    Author: Zhang, Linjie; Deng, Yuxiang; Liu, Songran; Zhang, Weili; Hong, Zhigang; Lu, Zhenhai; Pan, Zhizhong; Wu, Xiaojun; Peng, Jianhong
    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-022-10416-7
        PubMed      DOI
    7.Clinical significance of histopathological features of paired recurrent gliomas: a cohort study from a single cancer center

    Author: Li, Cong; Xi, Shaoyan; Chen, Yingshen; Guo, Chengcheng; Zhang, Ji; Yang, Qunying; Wang, Jian; Sai, Ke; Zeng, Jing; Wang, Jing; Zhang, Zhiqiang; Ke, Chao; Chen, Zhongping
    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-022-10484-9
        PubMed      DOI
    8.Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma

    Author: Jia, Guo-Dong; Sun, Xue-Song; Li, Xiao-Yun; Liu, Sai-Lan; Yang, Jin-Hao; Chen, Qiu-Yan; Yuan, Li; Mai, Hai-Qiang
    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-022-10494-7
        PubMed      DOI
    9.The Effect of immunonutrition in patients undergoing pancreaticoduodenectomy: a systematic review and meta-analysis

    Author: Fan, Yinyin; Li, Nianxing; Zhang, Jing; Fu, Qiaomei; Qiu, Yudong; Chen, Yan
    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-023-10820-7
        PubMed      DOI
    10.The V protein in oncolytic Newcastle disease virus promotes HepG2 hepatoma cell proliferation at the single-cell level

    Author: Chu, Zhili; Yang, Sihui; Li, Qianru; Shang, Jianing; Ren, Zilong; Ren, Feng
    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-023-10815-4
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity065.50
    Living Reviews in Relativity7565.50
    JOURNAL OF TRAVEL MEDICINE5119.60
    Military Medical Research030.10
    Advanced Composites and Hybrid Materials016.90
    INTERNATIONAL JOURNAL OF COMPUTER VISION17222.50
    Eurosurveillance9027.70
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE715.70
    Small Structures00.00
    Trends in Chemistry032.10


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共1011条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451